Clinical immunology最新文献

筛选
英文 中文
Infection risk associated with hypogammaglobulinemia in patients with systemic lupus erythematosus: Real-world evidence from 2014 to 2024 系统性红斑狼疮患者感染风险与低丙种球蛋白血症相关:2014年至2024年的真实世界证据
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-20 DOI: 10.1016/j.clim.2025.110568
Yang Liu , Sumiao Liu , Ying Liu, Qian Li, Ke Xu
{"title":"Infection risk associated with hypogammaglobulinemia in patients with systemic lupus erythematosus: Real-world evidence from 2014 to 2024","authors":"Yang Liu ,&nbsp;Sumiao Liu ,&nbsp;Ying Liu,&nbsp;Qian Li,&nbsp;Ke Xu","doi":"10.1016/j.clim.2025.110568","DOIUrl":"10.1016/j.clim.2025.110568","url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate infection risk associated with hypogammaglobulinemia in patients with systemic lupus erythematosus (SLE).</div></div><div><h3>Methods</h3><div>We retrospectively analyzed 242 cases of hypogammaglobulinemia identified among 3565 hospitalized SLE patients between 2014 and 2024. Of these, 133 experienced infections, while 109 remained infection-free and served as controls.</div></div><div><h3>Results</h3><div>Infection rates were comparable among patients with low IgG (60.0 %), IgM (56.3 %) and IgA (57.7 %) levels. Multivariate logistic regression identified low body weight, fever, medication discontinuation, lymphopenia, reduced lymphocyte count, elevated CRP levels, and decreased Th cell and NK cell counts as independent predictors of infection. During follow-up, immunoglobulin levels recovered in most patients, with rates at two years of 76.0 % for IgA, 43.8 % for IgG, and 26.2 % for IgM. Immunoglobulin normalization was associated with reduced infection risk.</div></div><div><h3>Conclusion</h3><div>Hypogammaglobulinemia increases infection risk in SLE due to multifactorial immune dysfunction. Modifiable clinical and immunologic factors, along with immunoglobulin recovery, may represent actionable targets for intervention.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110568"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144686317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-associated neutrophils: a complex role in cancer 肿瘤相关中性粒细胞:在癌症中的复杂作用。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-07 DOI: 10.1016/j.clim.2025.110558
Xukang Gao , Min Xu , Hao Xiao , Zeping Han , Zhutao Wang , Guoqiang Sun , Dai Zhang , Qiu Shuangjian , Ning Ren , Chenhao Zhou , Yong Yi
{"title":"Tumor-associated neutrophils: a complex role in cancer","authors":"Xukang Gao ,&nbsp;Min Xu ,&nbsp;Hao Xiao ,&nbsp;Zeping Han ,&nbsp;Zhutao Wang ,&nbsp;Guoqiang Sun ,&nbsp;Dai Zhang ,&nbsp;Qiu Shuangjian ,&nbsp;Ning Ren ,&nbsp;Chenhao Zhou ,&nbsp;Yong Yi","doi":"10.1016/j.clim.2025.110558","DOIUrl":"10.1016/j.clim.2025.110558","url":null,"abstract":"<div><div>Neutrophils, constituting 50–70 % of circulating leukocytes, serve as first responders in innate immunity. In recent years, as research into the tumor immune microenvironment has intensified, the role of neutrophils in tumor has gained increasing attention. Studies have shown that neutrophils are involved in tumor growth, metastasis, angiogenesis, and immune regulation. However, because tumor-associated neutrophils (TANs) often exhibit dual-edged effects and significant heterogeneity, it remains challenging to determine whether they act as allies or adversaries. This review systematically summarizes the classification and functions of neutrophils in tumor. Additionally, the current challenges in tumor-associated neutrophils are discussed, aiming to provide new insights for the development of neutrophil-related immunotherapies.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110558"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium 有和没有HIV的肾移植供者的炎症:多中心希望在行动联盟。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-11 DOI: 10.1016/j.clim.2025.110563
Fatima Zaman , Xianming Zhu , Joanne H. Hunt , Gracie Rozek , Yolanda Eby , Sarah Hussain , Niraj M. Desai , Sander Florman , Meenakshi M. Rana , Rachel Friedman-Moraco , Marcus R. Pereira , Shikha Mehta , Peter Stock , Alexander Gilbert , Jonathan Hand , Michele I. Morris , Valentina Stosor , Sapna A. Mehta , Catherine B. Small , Joanna Schaenman , Aaron A.R. Tobian
{"title":"Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium","authors":"Fatima Zaman ,&nbsp;Xianming Zhu ,&nbsp;Joanne H. Hunt ,&nbsp;Gracie Rozek ,&nbsp;Yolanda Eby ,&nbsp;Sarah Hussain ,&nbsp;Niraj M. Desai ,&nbsp;Sander Florman ,&nbsp;Meenakshi M. Rana ,&nbsp;Rachel Friedman-Moraco ,&nbsp;Marcus R. Pereira ,&nbsp;Shikha Mehta ,&nbsp;Peter Stock ,&nbsp;Alexander Gilbert ,&nbsp;Jonathan Hand ,&nbsp;Michele I. Morris ,&nbsp;Valentina Stosor ,&nbsp;Sapna A. Mehta ,&nbsp;Catherine B. Small ,&nbsp;Joanna Schaenman ,&nbsp;Aaron A.R. Tobian","doi":"10.1016/j.clim.2025.110563","DOIUrl":"10.1016/j.clim.2025.110563","url":null,"abstract":"<div><div>Kidney transplantation from donors with HIV has recently become standard clinical practice, but the plasma inflammatory profile is not well characterized. Thirty-two cytokines and chemokines were evaluated among donors with HIV (<em>n</em> = 63) and without HIV (<em>n</em> = 41). Wilcoxon rank sum test was used to compare cytokines between groups. Donors with and without HIV were generally similar in terms of characteristics, except those with HIV had a non-significantly lower kidney donor profile index, reflecting better graft survival, creatinine, and body mass index. Most cytokine and chemokine levels were similar between groups. However, median IL-8 levels were higher (<em>p</em> &lt; 0.0015) in donors without HIV (32.6 pg/mL, IQR = 13.8–394.9) compared to donors with HIV (15.1 pg/mL, IQR = 8.4–35.5). There were no significant correlations between cytokine and chemokine concentrations and CD4 counts or HIV viral load. In summary, inflammatory profiles were similar or lower among donors with HIV compared to donors without HIV supporting the safety of this emerging kidney transplantation practice.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110563"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144625481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dimensional immune profiling identifies circulating NK and T cell subpopulations associated with asymptomatic COVID-19 and absence of multiple long-term symptoms 高维免疫谱识别与无症状COVID-19和无多种长期症状相关的循环NK和T细胞亚群。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-11 DOI: 10.1016/j.clim.2025.110564
Johanna Bodin , Anja Bråthen Kristoffersen , Tove Karin Herstad , Gro Tunheim , Sabin Bhandari , Anna Hayman Robertson , Ratnadeep Mukherjee , Unni Cecilie Nygaard , Fredrik Oftung , Lisbeth M. Næss
{"title":"High-dimensional immune profiling identifies circulating NK and T cell subpopulations associated with asymptomatic COVID-19 and absence of multiple long-term symptoms","authors":"Johanna Bodin ,&nbsp;Anja Bråthen Kristoffersen ,&nbsp;Tove Karin Herstad ,&nbsp;Gro Tunheim ,&nbsp;Sabin Bhandari ,&nbsp;Anna Hayman Robertson ,&nbsp;Ratnadeep Mukherjee ,&nbsp;Unni Cecilie Nygaard ,&nbsp;Fredrik Oftung ,&nbsp;Lisbeth M. Næss","doi":"10.1016/j.clim.2025.110564","DOIUrl":"10.1016/j.clim.2025.110564","url":null,"abstract":"<div><div>While severe COVID-19 is well-characterized, immune profiles of non-hospitalized, non-vaccinated individuals are less investigated. High-dimensional single-cell profiling and multiplex serum marker analysis characterized immune profiles according to outcome during acute infection and six months later. Lower IL-1RA and HGF levels, higher CD57<sup>+</sup>TIGIT<sup>+</sup>NKT, CD57<sup>+</sup>GrB<sup>+</sup>NKT, CD16<sup>+</sup>TIGIT<sup>+</sup>NK and CD4<sup>+</sup>CD57<sup>+</sup>GrB<sup>+</sup> effector T-cell levels characterized asymptomatic infection. PMA + ionomycin induced higher frequencies of polyfunctional CD4<sup>+</sup> and CD8<sup>+</sup> effector T-cells in asymptomatic compared to moderate disease. Absence of multiple long-term symptoms was associated with higher CD16<sup>+</sup>TIGIT<sup>+</sup>NK-cell frequency, lower HGF levels and persisting high memory B and regulatory NK subpopulation levels. Higher frequency of CD16<sup>+</sup>TIGIT<sup>+</sup> NK cells was in common for non-infected, asymptomatic, and individuals without multiple long-term symptoms. Compared to infected individuals, non-infected cases showed higher pre-existing T-cell responses to hCoV and SARS-CoV-2 peptides. This study contributes to increased understanding of protective immune responses in non-hospitalized COVID-19 cases, emphasizing the role of defined NK and T-cell subpopulations.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110564"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144625480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients 转移性黑色素瘤患者外周血NK细胞对抗pd -1治疗的反应分析。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-09 DOI: 10.1016/j.clim.2025.110557
Katarina Mirjačić Martinović , Ana Vuletić , Nevena Tišma Miletić , Milica Nedeljković , Suzana Matković , Vladimir Jurišić
{"title":"Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients","authors":"Katarina Mirjačić Martinović ,&nbsp;Ana Vuletić ,&nbsp;Nevena Tišma Miletić ,&nbsp;Milica Nedeljković ,&nbsp;Suzana Matković ,&nbsp;Vladimir Jurišić","doi":"10.1016/j.clim.2025.110557","DOIUrl":"10.1016/j.clim.2025.110557","url":null,"abstract":"<div><div>Therapeutical blockade of programmed cell death protein 1 (PD-1) axis may enhance anti-tumor immunity and especially natural killer (NK) cells activity. In 32 BRAF wild type (wt) metastatic melanoma (MM) patients before and after every 12 weeks of therapy with PD-1 inhibitor, Pembrolizumab, we analyzed the percentage of T cell subsets, NK cells and CD14<sup>+</sup>HLA-DR<sup>−</sup> monocytes, the expression of CD107a degranulation marker, activating NKG2D, NKp46, DNAM-1 and inhibitory CD158a receptors on NK cells by Flow cytometry, until one year or disease progression (DP). The patients with disease control (non-DP patients) had significant increase in lymphocyte count, percentage of NK cells, increased expression of CD107a, NKG2D, NKp46, but decreased CD158a on NK cells during Pembrolizumab therapy compared to pretherapy values. Patients with DP had increased neutrophil number, increased percentage of immunosuppressive CD14<sup>+</sup>HLA-DR<sup>−</sup> monocytes, as well as increased CD158a expression on NK cells. In MM patients with disease control, contrary to DP patients blocking of PD-1 inhibitory molecule may increase NK cell cytotoxicity through enhancement of NK cell degranulation and activating receptor expression. Therefore, our findings show that NK cells and their receptors in MM patients may be potential biomarkers of response to Pembrolizumab.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110557"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144616547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LSP1 deficiency increases IL-17-expressing T cells and accelerates primary Sjögren's syndrome LSP1缺乏增加表达il -17的T细胞,加速原发性Sjögren综合征。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-06-28 DOI: 10.1016/j.clim.2025.110548
Jayhyun Kim , Jung Gon Kim , Yingjin Li , Sungyong You , Naeun Lee , Wan-Uk Kim
{"title":"LSP1 deficiency increases IL-17-expressing T cells and accelerates primary Sjögren's syndrome","authors":"Jayhyun Kim ,&nbsp;Jung Gon Kim ,&nbsp;Yingjin Li ,&nbsp;Sungyong You ,&nbsp;Naeun Lee ,&nbsp;Wan-Uk Kim","doi":"10.1016/j.clim.2025.110548","DOIUrl":"10.1016/j.clim.2025.110548","url":null,"abstract":"<div><div>Lymphocyte-specific protein-1 (LSP1) is known to negatively regulate T cell migration in autoimmune diseases. However, its role in the development of T cell-dependent Sjögren's syndrome remains unknown. In this study, we found that LSP1 expression was decreased in T cells in salivary glands (SGs) of mice with experimental Sjögren's syndrome, accompanied by enhanced infiltration of leukocytes into SGs. Moreover, <em>Lsp1</em><sup><em>−/−</em></sup> mice had higher frequency of IL-17A-expressing T cells in cervical lymph nodes as well as increased severity in SGs than WT mice. Concurrently, LSP1 expression was reduced in human T cells of primary Sjögren's syndrome (pSS) patient. Particularly, pSS patients showed an increased Th17 cells, which inversely correlated with LSP1 expression. Taken together, these findings suggest that LSP1 deficiency promote Th17 cell development and exacerbation of pSS. LSP1 might be a potential therapeutic target to regulate Th17 response and to treat autoimmune diseases like pSS.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110548"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Origin, functions, heterogeneity and associated diseases of B-1 cells B-1细胞的起源、功能、异质性和相关疾病。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-10 DOI: 10.1016/j.clim.2025.110561
Weicheng Shen , Shengyan Cui , Yanqi Xia , Luo Duan , Yunpeng Dou , Han Zhao , Leixin Liu , Wei Wang , Ye Cui , Yan Chen , Jie Liu , Zhe Lv , Chris J. Corrigan , Huihui Yuan , Ying Sun
{"title":"Origin, functions, heterogeneity and associated diseases of B-1 cells","authors":"Weicheng Shen ,&nbsp;Shengyan Cui ,&nbsp;Yanqi Xia ,&nbsp;Luo Duan ,&nbsp;Yunpeng Dou ,&nbsp;Han Zhao ,&nbsp;Leixin Liu ,&nbsp;Wei Wang ,&nbsp;Ye Cui ,&nbsp;Yan Chen ,&nbsp;Jie Liu ,&nbsp;Zhe Lv ,&nbsp;Chris J. Corrigan ,&nbsp;Huihui Yuan ,&nbsp;Ying Sun","doi":"10.1016/j.clim.2025.110561","DOIUrl":"10.1016/j.clim.2025.110561","url":null,"abstract":"<div><div>B-1 cells are derived from a subpopulation of B lymphocytes which have a specific developmental process, unique phenotype and location, and distinct functions in comparison with conventional B-2 cells. The origin of B-1 cells is not completely clear, with two existing hypotheses concerning their lineage and differentiation pathways. B-1 cells are located principally in the peritoneal and pleural cavities, but are also distributed in secondary lymphoid tissues, at mucosal sites and in the blood and bone marrow. B-1 cells regulate immune responses and maintain homeostasis by secretion of natural antibodies (nAbs), and participate in the adaptive immune response through phagocytosis and presentation of antigens to T cells. B-1 cells are associated with many diseases including autoimmune, infectious and inflammatory diseases. This review focuses on the origin and biological functions of B-1 cells as well as their involvement in human disease, and discusses advances in the understanding of the heterogeneity of B-1 cells under specific pathophysiological features, as partly clarified by single-cell sequencing analysis.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110561"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144616549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron-dependent cell death: Unlocking Ferroptosis as a key to multiple myeloma therapy 铁依赖性细胞死亡:解锁铁下垂作为多发性骨髓瘤治疗的关键。
IF 3.8 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-16 DOI: 10.1016/j.clim.2025.110570
Fatemeh Karimian , Melika Khademi , Amirsalar Nikkhah Bahrami , Maryam Nabigol , Fatemeh Mikanik , Mehdi Bakhtiyaridovvombaygi , Nader Vazifeh Shiran
{"title":"Iron-dependent cell death: Unlocking Ferroptosis as a key to multiple myeloma therapy","authors":"Fatemeh Karimian ,&nbsp;Melika Khademi ,&nbsp;Amirsalar Nikkhah Bahrami ,&nbsp;Maryam Nabigol ,&nbsp;Fatemeh Mikanik ,&nbsp;Mehdi Bakhtiyaridovvombaygi ,&nbsp;Nader Vazifeh Shiran","doi":"10.1016/j.clim.2025.110570","DOIUrl":"10.1016/j.clim.2025.110570","url":null,"abstract":"<div><div>Ferroptosis is an iron-dependent cell death characterized by elevated levels of reactive oxygen species (ROS) and the peroxidation of membrane lipids, leading to cellular destruction. This phenomenon results from a disruption in the balance between oxidative and antioxidative processes, with oxidation involving iron and lipid metabolism, and antioxidation primarily relying on GPX4. Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled plasma cell growth, accounting for 1.3 % of all malignancies. Despite advancements in treatment, MM still has a poor prognosis. Research indicates that malignant MM cells are susceptible to ferroptosis, suggesting that this process may serve as a novel therapeutic strategy to enhance the efficacy of treatment for MM. This review explores current insights into the cellular mechanisms of ferroptosis and its role in eliminating multiple myeloma cells, as well as its effectiveness alongside conventional drugs like Bortezomib.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110570"},"PeriodicalIF":3.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144667246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of signaling lymphocytic activation molecule (SLAM) family receptors in health and disease progression: Focusing on cancer and therapy 信号淋巴细胞活化分子(SLAM)家族受体在健康和疾病进展中的作用:聚焦于癌症和治疗
IF 3.8 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-26 DOI: 10.1016/j.clim.2025.110574
Guhan Luo , Rong Ni , Xuanwei Huang , Yuanhui Li , Dingcun Luo
{"title":"The role of signaling lymphocytic activation molecule (SLAM) family receptors in health and disease progression: Focusing on cancer and therapy","authors":"Guhan Luo ,&nbsp;Rong Ni ,&nbsp;Xuanwei Huang ,&nbsp;Yuanhui Li ,&nbsp;Dingcun Luo","doi":"10.1016/j.clim.2025.110574","DOIUrl":"10.1016/j.clim.2025.110574","url":null,"abstract":"<div><div>The SLAM family receptors are immunoglobulin superfamily receptors integral to immune cell communication and regulation. This review consolidates current knowledge on the structures and functions of SLAM family receptors members (SLAMF1–SLAMF9), emphasizing their roles within the tumor microenvironment. Notably, SLAMF7 has been extensively studied in multiple myeloma, serving as both a diagnostic marker and therapeutic target. Other SLAM family receptors are implicated in tumor immune evasion, drug resistance, and T-cell exhaustion. Emerging therapies, including monoclonal antibodies and combinations with immune checkpoint inhibitors, are evaluated. Despite promising findings, challenges such as functional redundancy and an incomplete understanding of the roles of SLAM family receptors across different cancer types persist. Ongoing research into their molecular mechanisms and clinical applications is essential for advancing effective cancer immunotherapies.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110574"},"PeriodicalIF":3.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Animal models of IgG4-related disease igg4相关疾病的动物模型。
IF 4.5 3区 医学
Clinical immunology Pub Date : 2025-11-01 Epub Date: 2025-07-06 DOI: 10.1016/j.clim.2025.110559
Manqi Tang , Weicheng Shen , Yanying Liu
{"title":"Animal models of IgG4-related disease","authors":"Manqi Tang ,&nbsp;Weicheng Shen ,&nbsp;Yanying Liu","doi":"10.1016/j.clim.2025.110559","DOIUrl":"10.1016/j.clim.2025.110559","url":null,"abstract":"<div><div>Immunoglobulin G4-Related Disease (IgG4-RD) is a recently characterized systemic autoimmune disorder marked by multiorgan inflammation and progressive fibrosis. It can affect nearly any organ and may lead to serious clinical consequences. Despite recent progress in developing animal models, therapeutic options for IgG4-RD remain limited, and the pathogenic mechanisms underlying immune dysregulation and fibrosis are still not fully understood. To support mechanistic and therapeutic research, both humanized and non-humanized animal models have been established in recent years. However, the unique biological features of the IgG4 molecule, together with genetic differences between humans and mice, present significant challenges to conventional mouse models. Although several models replicate certain features of IgG4-RD, none fully recapitulate the pathological hallmarks observed in patients. This review critically examines the strengths and limitations of current experimental models and outlines future directions for improving IgG4-RD model systems to better reflect human disease pathogenesis.</div></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"280 ","pages":"Article 110559"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144590537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书